Protagonist Therapeutics, Inc (PTGX) operating KPIs
PTGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/30299% above fair value
$144.85+0.51 (+0.35%)
Close on Oct 30, 2026Market cap $9.37BP/E 140.6Yield –
KPIs
Operating metrics that drive Protagonist Therapeutics's business
Coming soon
This tab will track the numbers specific to Protagonist Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.